Weed, or cannabis, activates a network of receptors throughout your brain and body that influence everything from mood and appetite to heart rate and memory. The main psychoactive compound, THC, mimics natural signaling molecules your body already produces, which is why its effects are so wide-ranging. What you actually feel depends on the dose, how you consume it, and how often you use it.
How THC Works in Your Brain
Your brain has a built-in signaling system called the endocannabinoid system, which uses its own cannabis-like molecules to regulate mood, pain, appetite, and sleep. THC hijacks this system by binding to the same receptors, called CB1 receptors, that your natural molecules use. These receptors are concentrated in areas that control memory (the hippocampus), movement coordination (the cerebellum), decision-making (the cortex), and emotional processing (the amygdala). That’s why a single substance can simultaneously make you feel relaxed, clumsy, forgetful, and hungry.
THC is what pharmacologists call a “partial agonist,” meaning it activates these receptors but not as fully as some synthetic compounds would. It also interacts with a second type of receptor, CB2, found mainly in immune cells, the spleen, liver, and gut. This partly explains why cannabis can affect inflammation and digestion, not just your mental state.
What You Feel Right Away
The immediate effects of weed vary from person to person, but the most common include euphoria or a sense of relaxation, heightened sensory perception, increased appetite, dry mouth, and red eyes. Your heart rate increases in a dose-dependent way, and your blood pressure may rise slightly before dropping. One large study using national health data found that recent cannabis use was associated with a small but measurable increase in systolic blood pressure.
THC has a well-documented biphasic effect on anxiety, meaning low and high doses do opposite things. At low doses, it tends to reduce anxiety by dampening excitatory signaling between neurons. At higher doses, it can trigger anxiety or even panic by overstimulating a different set of nerve cells. This is why the same person might feel calm after a few puffs and deeply anxious after consuming too much, and why inexperienced users are more likely to have a bad experience with potent products.
Effects on Thinking and Coordination
While you’re high, several cognitive abilities take a measurable hit. Working memory, the ability to hold information in your head and use it, has been shown to decline under THC’s influence for over 40 years of research. People under the influence take longer to complete memory tasks, and the impairment is worse at higher doses.
Attention, decision-making, impulse control, and motor coordination are all affected during acute intoxication. In controlled studies, people given THC made fewer correct decisions, took longer to respond, and were more impulsive compared to those given a placebo. These impairments are most pronounced in the first few hours and are a major reason why driving while high is dangerous. The acute cognitive window in most research extends from immediately after use up to about six hours, though individual experiences vary based on tolerance and dose.
Smoking vs. Edibles
How you consume weed dramatically changes the experience. When you smoke or vape cannabis, THC travels from your lungs to your brain almost instantly. Effects typically begin within minutes and peak within 30 minutes or so. When you eat an edible, absorption is 30 to 90 minutes slower because the THC has to pass through your digestive system first. In research settings, blood levels of THC and its metabolites begin to peak around 60 minutes after oral consumption on average.
Edibles also hit differently because of what happens in your liver. When THC is swallowed, your liver converts a significant portion of it into a metabolite called 11-hydroxy-THC. This metabolite crosses into the brain more easily than THC itself and is at least as potent, possibly more so. One study found it was 153% as active as THC in pain-related tests. After oral ingestion, levels of this metabolite can be significantly higher than they are after smoking. This is why edibles often feel stronger and last longer than smoking the same amount of THC, and why it’s easy to overconsume if you don’t wait long enough for the effects to kick in.
Effects on the Lungs
Cannabis smoke contains many of the same irritants and toxins as tobacco smoke, which raises obvious questions about lung health. The picture is more nuanced than a simple “just as bad as cigarettes,” though. Regular cannabis smoking is associated with changes in airway function, including reduced airflow in the central airways, a pattern that mirrors what’s seen in tobacco smokers. Bronchial biopsies from cannabis smokers show tissue damage similar to that caused by tobacco.
However, the overall pattern of lung function changes differs from tobacco in some ways. Cannabis smokers tend to show increased lung volume measurements rather than the decreased capacity typical of tobacco smokers. Research on the lung’s ability to transfer oxygen (a marker of gas exchange efficiency) found that cannabis appeared to reduce this capacity in people who also smoked tobacco, suggesting an additive effect, but this reduction wasn’t seen in cannabis-only smokers. The long-term consequences of decades of cannabis smoking are still less well understood than those of tobacco, partly because study populations are harder to isolate from tobacco co-use.
What Happens to the Adolescent Brain
The risks of cannabis look different for teenagers than for adults, because the brain is still developing well into the mid-20s. Studies of adolescents who use cannabis heavily (roughly 100 or more times per year) have found measurable changes in brain structure. One study of 16- to 19-year-olds found decreased cortical thickness in the frontal brain regions responsible for planning and impulse control, along with changes in the insula, a region involved in self-awareness and emotional processing. These alterations were linked to how heavily they used and how young they were when they started.
White matter, the insulated wiring that connects different brain regions, also appears to be affected. Multiple studies have found poorer white matter integrity in adolescent cannabis users compared to non-users, particularly in the tracts connecting the frontal and parietal lobes. People who began using before age 17 showed decreased overall brain gray matter and changes in white matter volume. These structural differences don’t necessarily prove cannabis caused them on its own, since genetic and environmental factors also play a role, but the pattern is consistent enough that researchers consider adolescent use a genuine developmental concern.
Dependence and Cannabis Use Disorder
Cannabis is less addictive than alcohol, nicotine, or opioids, but regular use can lead to a recognized condition called cannabis use disorder. Over 20% of all people who use cannabis meet the criteria for this diagnosis, and among daily or weekly users, the rate climbs to about 33%.
The condition is diagnosed when someone experiences two or more of eleven possible problems: building tolerance (needing more to feel the same effect), withdrawal symptoms when stopping, using more than intended, unsuccessful attempts to cut back, spending excessive time obtaining or recovering from cannabis, giving up activities because of use, continuing despite physical or psychological problems it causes, failing to meet responsibilities, using in dangerous situations, experiencing cravings, and continuing despite relationship problems. Severity ranges from mild (two to three criteria) to severe (six or more). Withdrawal symptoms, which can include irritability, sleep difficulties, decreased appetite, and restlessness, typically peak within the first week of stopping and can last up to two weeks.
Medical Uses
Despite widespread use of cannabis products for various health conditions, the FDA has approved only one drug actually derived from the cannabis plant: a purified form of CBD used to treat seizures associated with two severe forms of childhood epilepsy (Lennox-Gastaut syndrome and Dravet syndrome) in patients two years and older. Three additional approved medications use synthetic versions of THC to treat nausea from cancer chemotherapy and appetite loss in AIDS patients. No whole-plant cannabis product has received FDA marketing approval for any condition.
This doesn’t mean cannabis has no therapeutic effects, but it does mean that many of the medical claims around it outpace the level of evidence regulators require. The gap between what people use cannabis for (chronic pain, anxiety, insomnia, inflammation) and what’s been rigorously proven in clinical trials remains wide.